Plasmapheresis to eliminate immunosuppressive alemtuzumab levels in a child with disseminated adenovirus infection after allogeneic stem cell transplantation

Bone Marrow Transplant. 2020 Aug;55(8):1671-1673. doi: 10.1038/s41409-020-0837-1. Epub 2020 Feb 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenoviridae Infections* / drug therapy
  • Alemtuzumab / therapeutic use
  • Child
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Immunosuppressive Agents
  • Plasmapheresis
  • Transplantation Conditioning

Substances

  • Immunosuppressive Agents
  • Alemtuzumab